BACKGROUND: To evaluate factors associated with osteoradionecrosis of the jaw (ORNJ) in patients with head and neck squamous cell carcinoma (HNSCC), focusing on jaw-related dose-volume histogram (DVH) parameters. METHODS: We retrospectively reviewed the medical records of 616 patients with HNSCC treated with curative-intent or postoperative radiation therapy (RT) during 2008-2018. Patient-related (age, sex, history of smoking or alcohol use, diabetes mellitus, performance status, pre-RT dental evaluation, pre- or post-RT tooth extraction), tumor-related (primary tumor site, T-stage, nodal status), and treatment-related (pre-RT surgery, pre-RT mandible surgery, induction or concurrent chemotherapy, RT technique) variables and DVH parameters (relative volumes of the jaw exposed to doses of 10 Gy-70 Gy [V10-70]) were investigated and compared between patients with and without ORNJ. The Mann-Whitney U test was used to compare RT dose parameters. Univariate and multivariate Cox regression analyses were used to assess factors associated with ORNJ development. Kaplan-Meier analyses were performed for cumulative ORNJ incidence estimation. RESULTS: Forty-six patients (7.5%) developed ORNJ. The median follow-up duration was 40 (range 3-145) months. The median time to ORNJ development was 27 (range 2-127) months. DVH analysis revealed that V30-V70 values were significantly higher in patients with than in those without ORNJ. In univariate analyses, primary tumor site, pre-RT mandible surgery, post-RT tooth extraction, and V60 > 14% were identified as important factors. In multivariate analyses, V60 > 14% (p = 0.0065) and primary tumor site (p = 0.0059) remained significant. The 3-year cumulative ORNJ incidence rates were 2.5% and 8.6% in patients with V60 ≤ 14% and > 14%, respectively (p < 0.0001), and 9.3% and 1.4% in patients with oropharyngeal or oral cancer and other cancers, respectively (p < 0.0001). CONCLUSIONS: V60 > 14% and oropharyngeal or oral cancer were found to be independent risk factors for ORNJ. These findings might be useful to minimize ORNJ incidence in HNSCC treated with curative RT.
BACKGROUND: To evaluate factors associated with osteoradionecrosis of the jaw (ORNJ) in patients with head and neck squamous cell carcinoma (HNSCC), focusing on jaw-related dose-volume histogram (DVH) parameters. METHODS: We retrospectively reviewed the medical records of 616 patients with HNSCC treated with curative-intent or postoperative radiation therapy (RT) during 2008-2018. Patient-related (age, sex, history of smoking or alcohol use, diabetes mellitus, performance status, pre-RT dental evaluation, pre- or post-RT tooth extraction), tumor-related (primary tumor site, T-stage, nodal status), and treatment-related (pre-RT surgery, pre-RT mandible surgery, induction or concurrent chemotherapy, RT technique) variables and DVH parameters (relative volumes of the jaw exposed to doses of 10 Gy-70 Gy [V10-70]) were investigated and compared between patients with and without ORNJ. The Mann-Whitney U test was used to compare RT dose parameters. Univariate and multivariate Cox regression analyses were used to assess factors associated with ORNJ development. Kaplan-Meier analyses were performed for cumulative ORNJ incidence estimation. RESULTS: Forty-six patients (7.5%) developed ORNJ. The median follow-up duration was 40 (range 3-145) months. The median time to ORNJ development was 27 (range 2-127) months. DVH analysis revealed that V30-V70 values were significantly higher in patients with than in those without ORNJ. In univariate analyses, primary tumor site, pre-RT mandible surgery, post-RT tooth extraction, and V60 > 14% were identified as important factors. In multivariate analyses, V60 > 14% (p = 0.0065) and primary tumor site (p = 0.0059) remained significant. The 3-year cumulative ORNJ incidence rates were 2.5% and 8.6% in patients with V60 ≤ 14% and > 14%, respectively (p < 0.0001), and 9.3% and 1.4% in patients with oropharyngeal or oral cancer and other cancers, respectively (p < 0.0001). CONCLUSIONS: V60 > 14% and oropharyngeal or oral cancer were found to be independent risk factors for ORNJ. These findings might be useful to minimize ORNJ incidence in HNSCC treated with curative RT.
Entities:
Keywords:
Dose-volume histogram; Head and neck squamous cell carcinoma; Osteoradionecrosis of the jaw
Authors: Francesca Caparrotti; Shao Hui Huang; Lin Lu; Scott V Bratman; Jolie Ringash; Andrew Bayley; John Cho; Meredith Giuliani; John Kim; John Waldron; Aaron Hansen; Li Tong; Wei Xu; Brian O'Sullivan; Robert Wood; David Goldstein; Andrew Hope Journal: Cancer Date: 2017-06-13 Impact factor: 6.860
Authors: Beth M Beadle; Kai-Ping Liao; Mark S Chambers; Linda S Elting; Thomas A Buchholz; K Kian Ang; Adam S Garden; B Ashleigh Guadagnolo Journal: Head Neck Date: 2012-11-14 Impact factor: 3.147
Authors: Adepitan A Owosho; Arvin Kadempour; SaeHee K Yom; Joseph Randazzo; C Jillian Tsai; Nancy Y Lee; Ashok R Shaha; Joseph M Huryn; Cherry L Estilo Journal: Oral Oncol Date: 2015-10-09 Impact factor: 5.337
Authors: Kristin Lang; Thomas Held; Eva Meixner; Eric Tonndorf-Martini; Oliver Ristow; Julius Moratin; Nina Bougatf; Christian Freudlsperger; Jürgen Debus; Sebastian Adeberg Journal: Head Face Med Date: 2022-02-26 Impact factor: 2.151
Authors: Maximilian Gottsauner; Clara Fehrer; Steffen Spoerl; Johannes Schuderer; Florian Zeman; Mathias Fiedler; Michael Maurer; Torsten E Reichert; Tobias Ettl Journal: J Clin Med Date: 2022-08-27 Impact factor: 4.964
Authors: Lucas G Sapienza; Justin J Thomas; Weiyuan Mai; Alexander N Hanania; Sandeep Hunjan; Vlad C Sandulache; Albert C Chen Journal: Rep Pract Oncol Radiother Date: 2022-07-29
Authors: Rebecca L Venchiarutti; Masako Dunn; Emma Charters; Kai Cheng; Catriona Froggatt; Payal Mukherjee; Christine Wallace; Dale Howes; David Leinkram; Jasvir Singh; Kevin Nguyen; Tsu-Hui Hubert Low; Sydney Ch'ng; James Wykes; Raymond Wu; Jonathan R Clark Journal: Cancers (Basel) Date: 2022-09-20 Impact factor: 6.575